Interferons in Relapsing-Remitting Multiple Sclerosis: Are There Benefits from Long-Term Use?

By Oscar Fernández  

CNS Drugs, Vol. 18, Iss. 15, 2004-01 ,pp. : 1057-1070

Adis International

Access to resources Recommend Favorite

Can We Ensure the Safe Use of Known Human Teratogens?: Introduction of Generic Isotretinoin in the US as an Example

By Margaret A. Honein   Cynthia A. Moore   J. David Erickson  

Drug Safety, Vol. 27, Iss. 14, 2004-01 ,pp. : 1069-1080

Adis International

Access to resources Recommend Favorite

Can We Ensure the Safe Use of Known Human Teratogens?: The iPLEDGE™ Test Case

By Honein Margaret A.  

Drug Safety, Vol. 30, Iss. 1, 2007-01 ,pp. : 5-15

Adis International

Access to resources Recommend Favorite

Long-term safety of ustekinumab for psoriasis

By Kumar Neal   Narang Kirti   Cressey Brienne D   Gottlieb Alice B  

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 757-765

Informa Healthcare

Access to resources Recommend Favorite

Studies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted?

By El-Mallakh Rif S.   Briscoe Brian  

CNS Drugs, Vol. 26, Iss. 2, 2012-02 ,pp. : 97-109

Adis International

Access to resources Recommend Favorite